Article Information
History
- June 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Laura C Bott1,†,
- Mitra Forouhan2,†,
- Maria Lieto3,4,
- Ambre J Sala1,
- Ruth Ellerington2,
- Janel O Johnson5,
- Alfina A Speciale2,
- Chiara Criscuolo4,
- Alessandro Filla4,
- David Chitayat6,
- Andrea H Nemeth7,
- Italian Undiagnosed Diseases Network,
- Francesco Angelucci8,
- Wooi Fang Lim2,
- Pasquale Striano9,
- Federico Zara9,
- Ingo Helbig10,
- Mikko Muona11,12,
- Carolina Courage12,
- Anna-Elina Lehesjoki12,
- Samuel F Berkovic13,
- V-ATPase Consortium,
- Kenneth H Fischbeck14,
- Francesco Brancati8,15,
- Richard I Morimoto1,
- Matthew JA Wood2,16 and
- Carlo Rinaldi2,*
- 1Department of Molecular Biosciences, Rice Institute for Biomedical Research, Northwestern University, Evanston, Illinois 60208, USA
- 2Department of Paediatrics, University of Oxford, Oxford OX1 3QX, UK
- 3Department of Physiology, Anatomy and Genetics, Oxford OX1 3QX, UK
- 4Department of Neurosciences, Reproductive and Odontostomatological Sciences Federico II University, Naples 80121, Italy
- 5Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892, USA
- 6Division of Clinical and Metabolic Genetics, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario M5G 1X8, Canada; The Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario M5G 1X5, Canada
- 7Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK
- 8Department of Life, Health and Environmental Sciences, University of L’Aquila, 67100 Coppito, L’Aquila, Italy
- 9Institute for Research, Hospitalization and Health Care (IRCCS) “G. Gaslini” Institute, Genova 16147, Italy
- 10Division of Neurology, Children’s Hospital of Philadelphia; The Epilepsy NeuroGenetics Initiative (ENGIN), Children’s Hospital of Philadelphia; Department of Biomedical and Health Informatics (DBHi), Children’s Hospital of Philadelphia; Department of Neurology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA
- 11Blueprint Genetics, 02150 Espoo, Finland
- 12Folkhälsan Research Center, Helsinki, Finland; Department of Medical and Clinical Genetics, Medicum, University of Helsinki, Helsinki 00290, Finland
- 13Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria 3010, Australia
- 14Neurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Maryland 20892, USA
- 15IRCCS San Raffaele Pisana, 00163 Roma, Italy
- 16Oxford Harrington Rare Disease Centre, University of Oxford, Oxford OX1 3QX, UK
- ↵*Correspondence to: Carlo Rinaldi, Department of Paediatrics, South Parks Road, OX1 3QX, Oxford, UK, E-mail: carlo.rinaldi{at}paediatrics.ox.ac.uk
↵† These authors contributed equally.
Posted June 07, 2021.
Biallelic and de novo variants in ATP6V0A1 cause progressive myoclonus epilepsy and developmental and epileptic encephalopathy
